GeoVax Announces Full Enrollment of Phase 1 Clinical Trial for 2nd Generation HIV/AIDS Vaccine

GeoVax Labs, Inc. , an Atlanta-based biopharmaceutical firm developing vaccines to prevent and treat HIV/AIDS, is pleased to announce full enrollment in a 48 patient Phase 1 trial testing the safety and …
Sexual Health News Headlines – Yahoo! News